Skip to content
Roboearth – Lifestyle
Author:
Nxera Pharma
Nxera Pharma Webinar for Financial Results Presentation – 2Q2026
July 15, 2026
Nxera Pharma to Receive US$10 Million Milestone Payment from AbbVie under Collaboration Targeting Neurological Diseases
June 30, 2026
Nxera Joins OpenFold AI Research Consortium Alongside Leading Global Pharmaceutical and AI Companies to Accelerate AI-enabled Drug Discovery
June 10, 2026
Nxera’s Vamorolone Granted Key Regulatory Designations Supporting Faster Access for Duchenne Muscular Dystrophy Patients in South Korea
June 1, 2026
Nxera’s President & CEO to Participate in a ‘Fireside Chat’ at the Jefferies New York Healthcare Conference 2026
May 26, 2026
←
Previous Page
1
2